跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Fefosaph - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Fefosaph
Approved
STANDARD
Fefosaph
Sapphire Lifesciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c827c4478714644f
Company
Sapphire Lifesciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
c827c4478714644f
Drug Approval Philippines Name
Fefosaph
Product Name
Fefosaph
Registration Number
DRP-16365
Brand Name
Fefosaph
Generic Name
Iron (as Ferrous Sulfate) + Folic Acid (Vitamin B9)
Dosage Form
Film-coated Tablet
Dosage Strength
60 mg/400 mcg
Manufacturer
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc.
Distributor
Nelpa Lifesciences, Inc.
Issuance Date
25 February 2025
Expiry Date
25 February 2030
Pharmacologic Category
Mineral/Vitamin
Classification
Over-the-Counter (OTC) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c827c4478714644f
Type
Standard
Back to Philippines FDA Approvals